Hannah McLoughlin

Hannah is a contentious intellectual property specialist with particular expertise in the life sciences sector. She provides strategic advice to clients on complex patent disputes, brand protection and trade mark, copyright and designs litigation. Hannah plays a central role as the lead associate in several high-profile pharmaceutical patent cases before the Irish Commercial Court and the Court of Appeal. Her expertise extends to managing day-to-day operations in complex IP litigation, including patent disputes, trade mark infringement, and copyright licensing matters. She also advises clients on domain name dispute resolution and social media takedown requests. Hannah provides critical pre-litigation and regulatory advice to her clients across a spectrum of industries and across all IP rights.

Year joined firm: 2022

• 2022 – 2025 Acted for Teva in 4 sets of patent infringement and invalidity proceedings against Bristol Myers Squibb concerning blockbuster drug Apixaban before the Commercial Court and the Court of Appeal. o 2025 Advising an emerging AI and education technology company on intellectual property protection.
•  2022 – 2025 Acting for several manufacturers of generic medicines in relation to non-infringement and patent invalidity opinions.

• BA Gaeilge agus Iriseoireacht (Journalism through Irish) - Dublin City University - 2016
• Postgrad Diploma in Intellectual Property and Technology Law - Law Society of Ireland - 2021
• Postgraduate Diploma in Intellectual Property Law and Practice - University of Oxford - 2025